Search Within

Dana Elizabeth Rathkopf

  1. "Cancer Research"
Formats
  1. Meeting Abstract (9)
Groups
  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Solid Tumor Oncology Division (9)
  4. Department of Pathology and Laboratory Medicine (4)
  5. GSK Faculty (4)
  6. Human Oncology and Pathogenesis Program (4)

More Groups

People
  1. Howard Scher (6)
  2. Anuradha Gopalan (3)
  3. Wassim Abida (3)
  4. Brett Carver (2)
  5. Charles Sawyers (2)
  6. Danielle Li (2)

More People

Years
  1. 2020 (3)
  2. 2019 (1)
  3. 2018 (1)
  4. 2015 (2)
  5. 2014 (1)
  6. 2012 (1)
Publications
  1. Cancer Research (9)
Publishers
  1. American Association for Cancer Research (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Sweeney, C. J.; Gillessen, S.; Rathkopf, D.; Matsubara, N.; Drake, C.; Fizazi, K.; Piulats, J. M.; Wysocki, P. J.; Buchschacher, G. L. Jr; Doss, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Identification of the cells of origin and tumor heterogeneity in neuroendocrine prostate cancer (NEPC) by single-cell analysis
    Meeting Abstract

    Zhao, J. L.; Zaidi, S.; Chan, J.; Wadosky, K.; Karthaus, W.; Choi, D.; Agudelo Rivera, A.; Gopalan, A.; Rathkopf, D.; Carver, B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
    Meeting Abstract

    Zhang, Z.; Karthaus, W.; Mota, J. M.; Mu, P.; Wu, C.; Abida, W.; Linton, E.; Lee, Y. S.; Lee, E.; Mao, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment
    Meeting Abstract

    Rathkopf, D. E.; Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W. R.; Shore, N. D.; Liu, G.; Higano, C.; Alumkal, J. J.; Hauke, R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Kelvin, J.; Lu, D.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Arslan, Z.; Prigozhina, N.; Brown, D.; Krupa, R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (AA)
    Meeting Abstract

    Rathkopf, D. E.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J. J.; Ryan, C. J.; Saleh, M. N.; Hauke, R. J.; Bandekar, R.; Maneval, E. C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A randomized phase 2 study of two doses of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Antonarakis, E. S.; Heath, E. I.; Smith, D. C.; Rathkopf, D.; Blackford, A. L.; Danila, D. C.; King, S.; Frost, A.; Ajiboye, A. S.; Zhao, M.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save